These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prognostic power of NT-proBNP in left ventricular non-compaction cardiomyopathy. Stämpfli SF; Erhart L; Hagenbuch N; Stähli BE; Gruner C; Greutmann M; Niemann M; Kaufmann BA; Jenni R; Held L; Tanner FC Int J Cardiol; 2017 Jun; 236():321-327. PubMed ID: 28268080 [TBL] [Abstract][Full Text] [Related]
6. N-terminal proBNP levels in patients with Chagas disease: a marker of systolic and diastolic dysfunction of the left ventricle. Barbosa MM; Nunes Mdo C; Ribeiro AL; Barral MM; Rocha MO Eur J Echocardiogr; 2007 Jun; 8(3):204-12. PubMed ID: 16651029 [TBL] [Abstract][Full Text] [Related]
7. Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping. Liang YD; Xu YW; Li WH; Wan K; Sun JY; Lin JY; Zhang Q; Zhou XY; Chen YC J Cardiovasc Magn Reson; 2020 Jan; 22(1):2. PubMed ID: 31902370 [TBL] [Abstract][Full Text] [Related]
8. Plasma N-terminal protype-B natriuretic peptide and restrictive mitral flow to risk-stratify patients with stage B heart failure. Dini FL; Whalley G; Poppe K; Fontanive P; Rosa GM; Doughty RN; Di Bello V Clin Cardiol; 2009 Dec; 32(12):711-7. PubMed ID: 20027664 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of NT-proBNP, 3D LA volume and LV dyssynchrony in patients with acute STEMI undergoing primary percutaneous intervention. Siva Sankara C; Rajasekhar D; Vanajakshamma V; Praveen Kumar BS; Vamsidhar A Indian Heart J; 2015; 67(4):318-27. PubMed ID: 26304563 [TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics and Long-term Predictors of Persistent Left Ventricular Systolic Dysfunction in Peripartum Cardiomyopathy. Li W; Li H; Long Y Can J Cardiol; 2016 Mar; 32(3):362-8. PubMed ID: 26586094 [TBL] [Abstract][Full Text] [Related]
11. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure. Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415 [TBL] [Abstract][Full Text] [Related]
12. Predicting poor left ventricular function recovery in Peripartum cardiomyopathy. Prameswari HS; Iswandi CP; Hasan M; Martanto E; Putra ICS; Kamarullah W; Dewi TI; Akbar MR J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2279018. PubMed ID: 37935592 [TBL] [Abstract][Full Text] [Related]
13. NT-proBNP Indicates Left Ventricular Impairment and Adverse Clinical Outcome in Patients With Tetralogy of Fallot and Pulmonary Regurgitation. Westhoff-Bleck M; Kornau F; Haghikia A; Horke A; Bertram H; Treptau J; Widder J; Bauersachs J; Brehm MU Can J Cardiol; 2016 Oct; 32(10):1247.e29-1247.e36. PubMed ID: 26927857 [TBL] [Abstract][Full Text] [Related]
14. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major. Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869 [TBL] [Abstract][Full Text] [Related]
15. Amount of left ventricular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction. Kim SW; Park SW; Lim SH; Kwon SU; Choi YJ; Park MK; Lee SC; Lee SH; Park JE; Jeon ES Clin Cardiol; 2006 Apr; 29(4):155-60. PubMed ID: 16649724 [TBL] [Abstract][Full Text] [Related]
16. Relation of N-Terminal Pro-B-Type Natriuretic Peptide and Left Ventricular Diastolic Function to Exercise Tolerance in Patients With Significant Valvular Heart Disease and Normal Left Ventricular Systolic Function. Hwang JW; Park SJ; Cho EJ; Kim EK; Lee GY; Chang SA; Choi JO; Lee SC; Park SW Am J Cardiol; 2017 Jun; 119(11):1846-1853. PubMed ID: 28391990 [TBL] [Abstract][Full Text] [Related]
17. In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial roles. Ricke-Hoch M; Hoes MF; Pfeffer TJ; Schlothauer S; Nonhoff J; Haidari S; Bomer N; Scherr M; Stapel B; Stelling E; Kiyan Y; Falk C; Haghikia A; Binah O; Arany Z; Thum T; Bauersachs J; van der Meer P; Hilfiker-Kleiner D Cardiovasc Res; 2020 Sep; 116(11):1875-1886. PubMed ID: 31711127 [TBL] [Abstract][Full Text] [Related]
18. Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure. Rusconi PG; Ludwig DA; Ratnasamy C; Mas R; Harmon WG; Colan SD; Lipshultz SE Am Heart J; 2010 Oct; 160(4):776-83. PubMed ID: 20934575 [TBL] [Abstract][Full Text] [Related]
19. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction. Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760 [TBL] [Abstract][Full Text] [Related]
20. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Haghikia A; Podewski E; Libhaber E; Labidi S; Fischer D; Roentgen P; Tsikas D; Jordan J; Lichtinghagen R; von Kaisenberg CS; Struman I; Bovy N; Sliwa K; Bauersachs J; Hilfiker-Kleiner D Basic Res Cardiol; 2013 Jul; 108(4):366. PubMed ID: 23812247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]